Pill Identifier Ranolazine - NDC 70771-1499
Ranolazine
Product Code 70771-1499
Ranolazine by Cadila Healthcare Limited is a orange oval tablet extended release about 17 mm in size, imprinted with 588. The product is a human prescription drug with active ingredient(s) ranolazine.
Ranolazine
Active Ingredient(s): Ranolazine
Inactive Ingredient(s):
- MICROCRYSTALLINE CELLULOSE
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
- HYPROMELLOSE 2910 (5 MPA.S)
- SODIUM HYDROXIDE
- MAGNESIUM STEARATE
- TITANIUM DIOXIDE
- POLYETHYLENE GLYCOL 400
- TALC
- FERRIC OXIDE YELLOW
- FERRIC OXIDE RED
- FERROSOFERRIC OXIDE
Cadila Healthcare Limited
Product Type: Human Prescription Drug
Dosage Form: Tablet, Extended Release
- Orange (C48331)
Product Packages
NDC Package Code | Package Description |
---|---|
70771-1499-1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1499-4 | 10 BLISTER PACK in 1 CARTON > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1499-2) |
70771-1499-5 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1499-6 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.